Plain-English translation of NCT04347187 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Atrial Fibrillation research guide โThis is a research registry โ a long-term tracking study โ for patients with atrial fibrillation (an irregular heartbeat) who are taking blood-thinning medications to prevent strokes. Researchers want to understand how safe these medications are when people take them for months and years, and what complications, if any, patients experience. By following 2,000 patients over time, the study aims to build real-world evidence about the benefits and risks of these treatments.
Patients with atrial fibrillation need blood-thinning medications to prevent dangerous blood clots and strokes, but doctors want to know more about the long-term safety of this medication โ specifically, how often serious bleeding or clotting problems occur in everyday practice, so they can better advise patients and improve treatment plans.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will be enrolled in a registry and monitored over one year while you continue taking your prescribed blood-thinning medication as part of your normal care. Researchers will track your medical records and check in with you to record any bleeding problems, clots, or other side effects you experience. There are no experimental drugs or procedures โ this study simply observes and documents what happens to patients like you who are already on this type of treatment.
AI-generated summary from trial data ยท Jun 22, 2026 ยท Not medical advice
Russia
Sponsor
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Enrollment target
~2,000 participants
Started
January 2015
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Ekaterina Kropacheva, PhD
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.